JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IA
6001
Innovative Solutions & Support
IA
$333M
| $10.4K | ﹤0.01% |
1,735
-3,000
| -63% | -$19K |
2023 Q3
3 quarters
|
|
|
BOLD
6002
Boundless Bio
BOLD
$58.9M
| $10.4K | ﹤0.01% |
+2,689
| New | +$25.7K |
2024 Q2
0 quarters
|
|
|
NCTY
6003
The9 Ltd
NCTY
$51.2M
| $10.3K | ﹤0.01% |
1,206
+1,187
| +6,247% | +$8.67K |
2023 Q3
3 quarters
|
|
6004
Bausch Health
BHC
$2.14B
| $10.3K | ﹤0.01% |
1,474
-61,157
| -98% | -$463K |
2013 Q2
44 quarters
|
|
6005
Oxford Square Capital
OXSQ
$139M
| $10.2K | ﹤0.01% |
3,461
+3,267
| +1,684% | +$10.2K |
2022 Q4
6 quarters
|
|
6006
CALL
UiPath
PATH
$6.94B
| $10.1K | ﹤0.01% |
+800
| New | +$13.8K |
2024 Q2
0 quarters
|
|
6007
Global Indemnity Group
GBLI
$361M
| $10.1K | ﹤0.01% |
326
| – | – |
2013 Q2
44 quarters
|
|
6008
FT Vest US Equity Enhance & Moderate Buffer ETF October
XOCT
$66.6M
| $10.1K | ﹤0.01% |
303
-15
| -5% | -$496 |
2024 Q1
1 quarter
|
|
6009
Invesco Variable Rate Investment Grade ETF
VRIG
$1.84B
| $10K | ﹤0.01% |
398
-1,133
| -74% | -$28.5K |
2024 Q1
1 quarter
|
|
6010
PGIM Short Duration Multi-Sector Bond ETF
PSDM
$245M
| $9.95K | ﹤0.01% |
197
-4,881
| -96% | -$246K |
2024 Q1
1 quarter
|
|
|
BHIL
6011
DELISTED
Benson Hill, Inc.
BHIL
| $9.89K | ﹤0.01% |
1,855
-5,413
| -74% | -$35.8K |
2021 Q3
11 quarters
|
|
|
TRVG
6012
trivago
TRVG
$356M
| $9.88K | ﹤0.01% |
4,916
-40
| -0.8% | -$96 |
2023 Q1
5 quarters
|
|
6013
a.k.a. Brands
AKA
$119M
| $9.87K | ﹤0.01% |
647
+600
| +1,277% | +$9.57K |
2024 Q1
1 quarter
|
|
6014
Telomir Pharmaceuticals
TELO
$80.5M
| $9.86K | ﹤0.01% |
2,050
-555
| -21% | -$3.46K |
2024 Q1
1 quarter
|
|
6015
Aclaris Therapeutics
ACRS
$649M
| $9.79K | ﹤0.01% |
8,904
-60,764
| -87% | -$71.4K |
2017 Q4
26 quarters
|
|
6016
Gevo
GEVO
$324M
| $9.78K | ﹤0.01% |
17,543
-91,688
| -84% | -$61.4K |
2019 Q4
18 quarters
|
|
6017
Evogene
EVGN
$6.88M
| $9.74K | ﹤0.01% |
1,497
-2,446
| -62% | -$17.1K |
2023 Q3
3 quarters
|
|
|
JBIO
6018
Jade Biosciences
JBIO
$876M
| $9.67K | ﹤0.01% |
166
+35
| +27% | +$23.2K |
2021 Q3
11 quarters
|
|
|
IBMN
6019
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
| $9.52K | ﹤0.01% |
359
-34
| -9% | -$898 |
2023 Q3
3 quarters
|
|
6020
Brilliant Earth
BRLT
$23.5M
| $9.37K | ﹤0.01% |
4,221
+4
| +0.1% | +$10 |
2023 Q2
4 quarters
|
|
|
CSAN
6021
DELISTED
Cosan
CSAN
| $9.37K | ﹤0.01% |
962
| – | – |
2021 Q1
13 quarters
|
|
6022
Village Farms International
VFF
$349M
| $9.35K | ﹤0.01% |
9,164
+6,073
| +196% | +$7.39K |
2022 Q4
6 quarters
|
|
6023
State Street SPDR S&P Global Dividend ETF
WDIV
$275M
| $9.34K | ﹤0.01% |
158
-69
| -30% | -$4.13K |
2014 Q3
39 quarters
|
|
6024
AltShares Merger Arbitrage ETF
ARB
$101M
| $9.15K | ﹤0.01% |
340
-246
| -42% | -$6.61K |
2023 Q4
2 quarters
|
|
|
GRRR
6025
Gorilla Technology Group
GRRR
$374M
| $9.15K | ﹤0.01% |
3,302
+2,061
| +166% | +$11K |
2023 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.